January 2017

R&D team of ZATA published the manuscript describing ZATA’s novel self-neutralizing oligonucleotides with enhance cellular uptake.

https://www.ncbi.nlm.nih.gov/pubmed/28074950

For more information about published compounds as well as viewing earlier patent application: WO/2016/081600 International application No.: PCT/US2015/061343